Karuna Therapeutics, Inc. Comprehensive Income
Karuna Therapeutics, Inc. reported Comprehensive Income of -$430.18 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-22.
Discontinued › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2024-02-22
- Karuna Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-12-31 was -$110.68M.
- Karuna Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-09-30 was -$118.41M.
- Karuna Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-06-30 was -$105.19M.
- Karuna Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-03-31 was -$95.90M.
- Karuna Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$430.18M.
- Karuna Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$279.13M.
- Karuna Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$144.34M.
- Karuna Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$68.52M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2023-12-31 | -$110.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$229.09M derived: sum of 2 quarters · filed 2024-02-22 | -$334.28M derived: sum of 3 quarters · filed 2024-02-22 | -$430.18M 10-K · filed 2024-02-22 |
| 2023-09-30 | -$118.41M 10-Q · filed 2023-11-02 | -$223.60M derived: sum of 2 quarters · filed 2023-11-02 | -$319.50M 10-Q · filed 2023-11-02 | -$395.30M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-06-30 | -$105.19M 10-Q · filed 2023-08-03 | -$201.09M 10-Q · filed 2023-08-03 | -$276.89M derived: sum of 3 quarters · filed 2024-02-22 | -$354.56M derived: sum of 4 quarters · filed 2024-02-22 |
| 2023-03-31 | -$95.90M 10-Q · filed 2023-05-04 | -$171.70M derived: sum of 2 quarters · filed 2024-02-22 | -$249.37M derived: sum of 3 quarters · filed 2024-02-22 | -$314.77M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-12-31 | -$75.80M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$153.47M derived: sum of 2 quarters · filed 2024-02-22 | -$218.87M derived: sum of 3 quarters · filed 2024-02-22 | -$279.13M 10-K · filed 2024-02-22 |
| 2022-09-30 | -$77.67M 10-Q · filed 2023-11-02 | -$143.07M derived: sum of 2 quarters · filed 2023-11-02 | -$203.32M 10-Q · filed 2023-11-02 | -$231.75M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$65.40M 10-Q · filed 2023-08-03 | -$125.66M 10-Q · filed 2023-08-03 | -$154.08M derived: sum of 3 quarters · filed 2024-02-22 | -$205.04M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$60.26M 10-Q · filed 2023-05-04 | -$88.68M derived: sum of 2 quarters · filed 2024-02-22 | -$139.64M derived: sum of 3 quarters · filed 2024-02-22 | -$174.07M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$28.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$79.38M derived: sum of 2 quarters · filed 2024-02-22 | -$113.81M derived: sum of 3 quarters · filed 2024-02-22 | -$144.34M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$50.96M 10-Q · filed 2022-11-03 | -$85.39M derived: sum of 2 quarters · filed 2022-11-03 | -$115.92M 10-Q · filed 2022-11-03 | -$140.26M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$34.43M 10-Q · filed 2022-08-08 | -$64.96M 10-Q · filed 2022-08-08 | -$89.30M derived: sum of 3 quarters · filed 2023-02-23 | -$108.67M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$30.53M 10-Q · filed 2022-05-05 | -$54.87M derived: sum of 2 quarters · filed 2023-02-23 | -$74.23M derived: sum of 3 quarters · filed 2023-02-23 | -$91.95M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$24.34M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$43.71M derived: sum of 2 quarters · filed 2023-02-23 | -$61.43M derived: sum of 3 quarters · filed 2023-02-23 | -$68.52M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$19.37M 10-Q · filed 2021-11-04 | -$37.09M derived: sum of 2 quarters · filed 2021-11-04 | -$44.18M 10-Q · filed 2021-11-04 | -$52.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$17.72M 10-Q · filed 2021-08-05 | -$24.81M 10-Q · filed 2021-08-05 | -$32.63M derived: sum of 3 quarters · filed 2022-02-24 | -$41.69M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$7.09M 10-Q · filed 2021-05-06 | -$14.91M derived: sum of 2 quarters · filed 2022-02-24 | -$23.97M derived: sum of 3 quarters · filed 2022-02-24 | -$39.04M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$7.82M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$16.88M derived: sum of 2 quarters · filed 2022-02-24 | -$31.95M derived: sum of 3 quarters · filed 2022-02-24 | -$43.95M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$9.06M 10-Q · filed 2020-11-05 | -$24.13M derived: sum of 2 quarters · filed 2020-11-05 | -$36.13M 10-Q · filed 2020-11-05 | -$44.46M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$15.07M 10-Q · filed 2020-08-05 | -$27.07M 10-Q · filed 2020-08-05 | -$35.40M derived: sum of 3 quarters · filed 2021-02-25 | -$41.64M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$12.01M 10-Q · filed 2020-05-07 | -$20.33M derived: sum of 2 quarters · filed 2021-02-25 | -$26.57M derived: sum of 3 quarters · filed 2021-02-25 | -$27.11M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$8.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$14.56M derived: sum of 2 quarters · filed 2021-02-25 | -$15.10M derived: sum of 3 quarters · filed 2021-02-25 | -$17.51M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$6.24M 10-Q · filed 2019-11-07 | -$6.78M derived: sum of 2 quarters · filed 2019-11-07 | -$9.19M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | -$539.00K 10-Q · filed 2019-08-08 | -$2.95M 10-Q · filed 2019-08-08 |